NIDA -- Identification of Biomarkers of HIV-1 Pathogenesis and Substance Abuse Comorbidity (R01- Clinical Trial Not Allowed)

Funding Agency:
National Institutes of Health

 The goal of this Funding Opportunity Announcement [FOA] is to support research that will define and validate a set(s) of molecular biomarkers and/or bio-signatures indicating the degree of loss of functional reserve, or of resilience of the host defense mechanisms, at different phases of HIV-1 pathogenesis in individuals with substance use disorders (SUDs). 


  • Letter of Intent Due Date(s): 30 days prior to the application due date
  • Application Due Date(s):  April 17, 2018
  • AIDS Application Due Date(s):  April 17, 2018

​RFA-DA-18-023 Expiration Date December 12, 2017




Environmental & Life Sciences
Medical - Basic Science
Medical - Clinical Science

External Deadline

April 17, 2018